Results 111 to 120 of about 3,056 (192)

Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study

open access: yesCNS Neuroscience &Therapeutics, Volume 30, Issue 8, August 2024.
Lacosamide (LCM) is effective, safe, and well‐tolerated as an adjunctive therapy in young Chinese children aged ≥1 month to ≤4 years. The order of lacosamide introduction significantly influenced its short‐term efficacy. Abstract Aims To evaluate the efficacy, safety, and tolerability of adjunctive lacosamide therapy against focal seizures in young ...
Lu Yang   +6 more
wiley   +1 more source

Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model [PDF]

open access: yes, 2016
Background: We recently reported that poly-arginine peptides have neuroprotective properties both in vitro and in vivo. In cultured cortical neurons exposed to glutamic acid excitotoxicity, we demonstrated that neuroprotective potency increases with ...
Anderton, R   +5 more
core   +2 more sources

GSK3: A potential target and pending issues for treatment of Alzheimer's disease

open access: yesCNS Neuroscience &Therapeutics, Volume 30, Issue 7, July 2024.
GSK3 signaling in Alzheimer's disease and targeted therapies. Abstract Glycogen synthase kinase‐3 (GSK3), consisting of GSK3α and GSK3β subtypes, is a complex protein kinase that regulates numerous substrates. Research has observed increased GSK3 expression in the brains of Alzheimer's disease (AD) patients and models.
Jiahui Zhao   +6 more
wiley   +1 more source

Mitochondria and neuroprotection in stroke: Cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics [PDF]

open access: yes, 2018
Stroke is the second leading cause of death globally and represents a major cause of devastating long-term disability. Despite sustained efforts to develop clinically effective neuroprotective therapies, presently there is no clinically available ...
Anderton, Ryan S   +4 more
core   +1 more source

Lithium alters expression of RNAs in a type-specific manner in differentiated human neuroblastoma neuronal cultures, including specific genes involved in Alzheimer's disease. [PDF]

open access: yes, 2019
Lithium (Li) is a medication long-used to treat bipolar disorder. It is currently under investigation for multiple nervous system disorders, including Alzheimer's disease (AD).
Balaraman, Yokesh   +7 more
core   +3 more sources

Edge‐wise analysis reveals white matter connectivity associated with focal to bilateral tonic–clonic seizures

open access: yesEpilepsia, Volume 65, Issue 6, Page 1756-1767, June 2024.
Abstract Objective Focal to bilateral tonic–clonic seizures (FBTCS) represent a challenging subtype of focal temporal lobe epilepsy (TLE) in terms of both severity and treatment response. Most studies have focused on regional brain analysis that is agnostic to the distribution of white matter (WM) pathways associated with a node.
Sam S. Javidi   +6 more
wiley   +1 more source

Центральные и гормональные механизмы адаптации к десинхронизационному стрессу

open access: yesИнтегративная физиология
На крысах-самцах линии Wistar создана модель 14-суточной десинхронизации циркадианного ритма. В первой серии исследований изучалось влияние десинхронизации на уровень белка 2, опосредующего активность коллапсина (collapsin-response mediator protein 2 ...
Парвин Асад кызы Зульфугарова   +1 more
doaj   +5 more sources

Efficacy of (S)-lacosamide in preclinical models of cephalic pain

open access: yesPAIN Reports, 2016
. Migraine is one of the world's most common neurological disorders. Current acute migraine treatments have suboptimal efficacy, and new therapeutic options are needed.
Aubin Moutal   +7 more
doaj   +1 more source

A high-fat diet induces rapid changes in the mouse hypothalamic proteome [PDF]

open access: yes, 2019
Funding LMW, FMC, CG, ACM and C-DM were funded by the Scottish Government’s Rural and Environment Science and Analytical Services Division (RESAS). FHM was supported by an EASTBIO DTP BBSRC studentship. DS was supported by a SULSA studentship.
Campbell, Fiona M.   +8 more
core   +3 more sources

Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation [PDF]

open access: yes, 2015
Increasing evidence suggests that recurrent Herpes Simplex Virus type 1 (HSV-1) infection spreading to the CNS is a risk factor for Alzheimer's Disease (AD) but the underlying mechanisms have not been fully elucidated yet.
De Chiara, Giovanna   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy